|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
GAAD Medical Research Institute Inc. |
|---|---|
| Information provided by: | GAAD Medical Research Institute Inc. |
| ClinicalTrials.gov Identifier: | NCT00674895 |
Purpose
Parkinson's disease (PD) is a degenerative disorder of the central nervous system that often impairs the sufferer's motor skills and speech. This study will investigate the use of far infrared radiation to manage, control and treat PD.
| Condition | Intervention | Phase |
|---|---|---|
|
Parkinson's Disease |
Radiation: Far Infrared Radiation (5μm to 20μm wavelength) |
Phase I |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
| Official Title: | Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Control and Treatment of Parkinson's Disease. |
| Estimated Enrollment: | 10 |
| Study Start Date: | May 2008 |
| Estimated Study Completion Date: | June 2010 |
| Estimated Primary Completion Date: | May 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
1: Experimental
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
|
Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
Radiation: Far Infrared Radiation (5μm to 20μm wavelength). Far Infrared radiation for 30 to 40 minutes per treatment session.
|
Parkinson's disease belongs to a group of conditions called movement disorders. It is characterized by muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement. The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. PD is both chronic and progressive.
Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.
It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have PD.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Canada, Ontario | |
| The Centre for Incurable Diseases | |
| Toronto, Ontario, Canada, M4V 1L5 | |
| Principal Investigator: | Ken Nedd, M.D. | GAAD Medical Research Institute Inc. |
More Information
| Responsible Party: | GAAD Medical Research Institute Inc. ( Dr. Kwasi Donyina/Founder and President ) |
| Study ID Numbers: | GAAD-PD-CTP1 |
| Study First Received: | May 6, 2008 |
| Last Updated: | January 2, 2009 |
| ClinicalTrials.gov Identifier: | NCT00674895 |
| Health Authority: | Canada: Health Canada |
|
Idiopathic Parkinson's Disease Lewy Body Parkinson's Disease Paralysis Agitans |
Parkinson's Disease, Idiopathic Parkinson's Disease, Lewy Body Primary Parkinsonism |
|
Paralysis Ganglion Cysts Movement Disorders Parkinson Disease Basal Ganglia Diseases |
Central Nervous System Diseases Parkinsonian Disorders Neurodegenerative Diseases Brain Diseases |
|
Nervous System Diseases |
